NEWARK, N.Y., Oct. 19, 2017 -- Ultralife Corporation (NASDAQ:ULBI) will report its third quarter results for the period ended October 1, 2017 before the market opens on Thursday, November 2, 2017.
Ultralife’s management will also host an investor conference call and simultaneous webcast at 10:00 AM ET on November 2, 2017. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations Section of the Company’s website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com.
Company Contact:
Ultralife Corporation
Philip A. Fain
(315) 210-6110
[email protected]
Investor Relations Contact:
LHA
Jody Burfening
(212) 838-3777
[email protected]


Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 



